REQUEST A DEMO
Total
USD $0.00
Search more companies

Inpharmus Ilac Sanayi Ticaret A.S. (Turkiye)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Inpharmus Ilac Sanayi Ticaret Anonim Sirketi Profile Updated: November 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

trpharm is a pharmaceutical industry company. The company focuses on developing solutions for various health needs, including rare diseases. trpharm also offers services for drug discovery, development, production, and regulatory work to accelerate the drug development process. The company is expanding its export activities internationally.

Headquarters
Kanyon Of.blg K.14 No:185 Esentepe Mahallesi Buyukdere Caddesi Sisli
Istanbul; Marmara; Postal Code: 34394

Contact Details: Purchase the Inpharmus Ilac Sanayi Ticaret A.S. report to view the information.

Website: http://www.trpharm.com

Basic Information
Total Employees:
Purchase the Inpharmus Ilac Sanayi Ticaret A.S. report to view the information.
Financial Auditors:
Purchase the Inpharmus Ilac Sanayi Ticaret A.S. report to view the information.
Incorporation Date:
June 11, 2013
Key Executives
Purchase this report to view the information.
Vice Chariman
Company Performance
Financial values in the chart are available after Inpharmus Ilac Sanayi Ticaret A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
-35.22%
Total operating revenue
-35.22%
Operating profit (EBIT)
-143.01%
Net Profit (Loss) for the Period
-143.01%
Total assets
66.23%
Total equity
N/A
Operating Profit Margin (ROS)
-6.39%
Net Profit Margin
-6.39%
Return on Equity (ROE)
N/A
Debt to Equity Ratio
N/A
Quick Ratio
0.75%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?